
"Sector" = median of Healthcare across 84 companies
Mouwasat Medical Services Co. is a leading healthcare provider in Saudi Arabia, operating a network of multi-specialty hospitals and medical centers. Founded in 1975, the company offers a comprehensive range of medical services including emergency care, surgery, cardiology, oncology, pediatrics, and diagnostic imaging. It is headquartered in Dammam and listed on the Saudi Stock Exchange (Tadawul) under ticker 4002.
The company generates revenue primarily from inpatient and outpatient medical services, including consultations, surgeries, laboratory tests, and radiology. It also earns from pharmacy sales and other ancillary services. Revenue is recognized at the point of service delivery, with a mix of private pay, insurance, and government contracts. The latest quarter (2026Q1) reported revenue of 833.80M SAR.
Mouwasat operates in the highly regulated healthcare sector in Saudi Arabia, competing with other private hospital groups such as Dr. Sulaiman Al Habib Medical Services and Dallah Healthcare. The company differentiates itself through a strong regional presence in the Eastern Province and a reputation for quality care. It holds a market cap of 13.10B SAR and a PE ratio of 15.94, reflecting stable profitability.
The primary customers are Saudi residents and expatriates seeking private medical care, with a focus on the Eastern Province. The company also serves patients from neighboring Gulf countries. Its main geographic market is Saudi Arabia, where it operates multiple hospitals and clinics, benefiting from the country's growing healthcare demand and government support for the sector.
An auto-generated descriptive profile based on company data, for informational purposes only.
Mouwasat Medical Services Co. stock closed at 66.15 SAR, unchanged from the previous session, with no significant price movement. No recent news or corporate announcements were reported in the last 24 hours, indicating a quiet period for the company. The stock continues to trade without notable catalysts, reflecting stable investor sentiment.
Latest saved period: March 2026 · 2026-03-31
Cash dividends by ex-date, not an investment recommendation.
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| Dec 7, 2025 | 1.00 SAR | — | — |
| May 6, 2025 | 2.00 SAR | — | — |
| May 28, 2024 | 1.75 SAR | — | — |
| May 8, 2023 | 1.50 SAR | — | — |
| May 10, 2022 | 1.38 SAR | — | — |
| May 2, 2021 | 1.25 SAR | — | — |
| Apr 23, 2020 | 1.00 SAR | — | — |
| Apr 23, 2019 | 0.88 SAR | — | — |
| May 3, 2018 | 0.75 SAR | — | — |
| Apr 25, 2017 | 0.63 SAR | — | — |
| Apr 5, 2016 | 0.50 SAR | — | — |
| Apr 2, 2015 | 0.50 SAR | — | — |
| Apr 3, 2014 | 0.50 SAR | — | — |
| Apr 3, 2013 | 0.38 SAR | — | — |
| Apr 3, 2012 | 0.38 SAR | — | — |
| Mar 29, 2011 | 0.25 SAR | — | — |
Wrqti brings Mouwasat Medical Services Co. data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Companies in the Healthcare sector you can compare with Mouwasat Medical Services Co.:
Compare Mouwasat Medical Services Co. head-to-head with:
When available, the page shows quarterly and annual statements plus ratios such as PE, price to book, profit margin, and free cash flow. Latest financial period shown: March 2026.
Wrqti content depends on available data and third-party sources and may include delays or errors. Review official company filings and consult a licensed financial advisor before making investment decisions. Read the data methodology.